Seroprevalence of Antibodies Specific to Receptor Binding Domain of SARS-CoV-2 and Vaccination Coverage Among Adults in Los Angeles County, April 2021: The LA Pandemic Surveillance Cohort Study

Neeraj Sood; Olivier Pernet; Chun Nok Lam; Angela Klipp; Rani Kotha; Andrea Kovacs; Howard Hu

doi:10.1001/jamanetworkopen.2021.44258

Seroprevalence of Antibodies Specific to Receptor Binding Domain of SARS-CoV-2 and Vaccination Coverage Among Adults in Los Angeles County, April 2021: The LA Pandemic Surveillance Cohort Study

JAMA Netw Open. 2022 Jan 4;5(1):e2144258. doi: 10.1001/jamanetworkopen.2021.44258.

Authors

Neeraj Sood^{1

2

3}, Olivier Pernet³, Chun Nok Lam³, Angela Klipp^{1

2}, Rani Kotha^{1

2}, Andrea Kovacs³, Howard Hu³

Affiliations

¹ Sol Price School of Public Policy, University of Southern California, Los Angeles.
² Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles.
³ Keck School of Medicine, University of Southern California, Los Angeles.

Abstract

This cross-sectional study estimates the seroprevalence of antibodies specific to the receptor binding domain of the spike protein of SARS-CoV-2 and vaccination coverage among adults in Los Angeles County, California, in April 2021.

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adolescent
Adult
Aged
Antibodies, Viral / blood*
COVID-19* / blood
COVID-19* / immunology
COVID-19* / prevention & control
COVID-19* / virology
Cohort Studies
Female
Humans
Immunity, Herd
Los Angeles / epidemiology
Male
Middle Aged
Pandemics*
SARS-CoV-2 / immunology*
Seroepidemiologic Studies
Spike Glycoprotein, Coronavirus / immunology
Vaccination Coverage*
Young Adult

Substances

Antibodies, Viral
Spike Glycoprotein, Coronavirus
spike glycoprotein, SARS-CoV

Grants and funding

R01 DA044111/DA/NIDA NIH HHS/United States